Nothing followed yet. Follow GLP-1 drugs to see its stories first on the front page.
Kept on this device.
Follow it to see its stories first on the front page.
Pharma companies that make GLP-1 drugs have increasingly promoted telehealth companies that prescribe the popular treatments. With a new deal announced this week, one of those relationships is expected to grow more complicated. Eli Lilly has been…
Tiny doses of GLP-1s are being marketed as antiaging drugs, but what evidence is there?
GLP-1 medications are everywhere these days. The peptide-based drugs are both highly effective and wildly popular for diabetes, weight loss and a growing range of connected chronic health conditions, including cardiovascular disease and obstructive…
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
The Food and Drug Administration is warning that popular obesity drugs—including Ozempic, Wegovy, Zepbound, and Mounjaro—may carry a "potential increased risk" of a rare eye condition that can lead to permanent vision loss. In a drug safety…
Top of the morning to you and a fine one it is. Blue skies, cool breezes, and plenty of chirping birds are enveloping the comfy Pharmalot campus, which is cause to fire up the coffee kettle for yet another cup of stimulation. Our choice today is…
Pick what should wake you up. We only push stories the AI rates as genuinely urgent.
The front page opens with the newest stories from these sources, in this order. Your choice is kept in a cookie on this device.
